ArticleHereditas2026
Linc01748 regulates the prognosis and related mechanisms of gastric cancer by targeting miR-130a-5p.
Article in Hereditas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveThe purpose of this study is to investigate the expression of linc01748 in gastric cancer (GC) tissues and cell lines, and to reveal the influence and potential mechanism of linc01748 on the biological behavior of GC cells.
methodsLinc01748 levels in GC were predicted through bioinformatics software. The proliferation, migration and invasion abilities of GC cells were respectively estimated by cell function tests. The RT-qPCR experiment was implemented to measure the levels of key proteins in epithelial-mesenchymal transition (EMT). The miRNAs regulated downstream of linc01748 were preliminarily screened through literature review and bioinformatics prediction. The relationship of miR-130a-5p to linc01748 was validated by dual-luciferase assay. The effect of the linc01748/miR-130a-5p axis on the expression of EMT-related genes was detected via in vitro cell experiments. MiR-130a-5p target genes were predicted using bioinformatics databases and verified by luciferase reporter gene experiments.
resultsLinc01748 expression in GC tissues and cell lines is significantly upregulated and is associated with prognosis. Linc01748 promotes the proliferation, migration and invasion of GC and regulates the expression of key proteins in EMT. miR-130a-5p is lowly expressed in GC and can mediate the cancer-promoting effect of linc01748. POU2F1 is the target gene of the linc01748/miR-130a-5p axis, and its expression is negatively correlated with miR-130a-5p.
conclusionLinc01748 is highly expressed in GC tissues and cell lines and is closely related to the prognosis. The linc01748/miR-130a-5p axis regulates POU2F1 expression, thereby facilitating the progression of GC and EMT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.